Influenza
Showing NaN - NaN of 88
SARS-CoV-2, Influenza Trial in Canada, United States (mRNA-1083, Placebo, Influenza Vaccine)
Not yet recruiting
- SARS-CoV-2
- Influenza
- mRNA-1083
- +3 more
-
Anniston, Alabama
- +172 more
Oct 18, 2023
SARS-CoV-2, Influenza Trial in United States (Fluarix, mRNA-1083.1, mRNA-1083.2)
Recruiting
- SARS-CoV-2
- Influenza
- Fluarix
- +8 more
-
Chandler, Arizona
- +68 more
Apr 24, 2023
COVID-19, Influenza Trial in Rochester (GRIP Electronic Diagnostic Chip, Laboratory-based nucleic acid amplification tests
Not yet recruiting
- COVID-19
- Influenza
- GRIP Electronic Diagnostic Chip
- Laboratory-based nucleic acid amplification tests (NAATs)
-
Rochester, MinnesotaMayo Clinic Minnesota
Dec 21, 2022
SARS-CoV-2, Influenza Trial in United States (mRNA-1073, mRNA-1010, mRNA-1273)
Active, not recruiting
- SARS-CoV-2
- Influenza
- mRNA-1073
- +3 more
-
Hollywood, Florida
- +13 more
Oct 5, 2022
Influenza Trial in Hollywood, Rochester, Mount Pleasant (Quadrivalent RIV with H3 strain 1, Quadrivalent RIV with H3 strain 2,
Completed
- Influenza
- Quadrivalent RIV with H3 strain 1
- +4 more
-
Hollywood, Florida
- +2 more
Apr 21, 2022
Respiratory Virus Hospitalization Study (FLU 003 Plus)
Recruiting
- Influenza
- +2 more
-
San Diego, California
- +62 more
Mar 28, 2022
Influenza, Influenza Immunisation Trial in Rochester (Influenza Virus Quadrivalent Inactivated Vaccine)
Completed
- Influenza
- Influenza Immunisation
- Influenza Virus Quadrivalent Inactivated Vaccine
-
Rochester, New YorkUniversity of Rochester Medical Center - Strong Memorial Hospita
Mar 17, 2022
Influenza Trial in Rochester (Fluad Vaccine, Fluzone High-Dose)
Active, not recruiting
- Influenza
- Fluad Vaccine
- Fluzone High-Dose
-
Rochester, MinnesotaMayo Clinic in Rochester
Dec 22, 2021
Influenza Trial in Rochester (FluBlok, Fluzone, FluCelVax)
Completed
- Influenza
- FluBlok
- +3 more
-
Rochester, New YorkUniversity of Rochester Medical Center, Vaccine Research Unit Ro
Nov 1, 2021
HIV, Influenza Trial in Puerto Rico, United States (Cold-adapted live attenuated influenza vaccine (FluMist), Inactivated
Completed
- HIV Infections
- Influenza
- Cold-adapted live attenuated influenza vaccine (FluMist)
- Inactivated influenza vaccine (IAIV)
-
Birmingham, Alabama
- +60 more
Oct 28, 2021
Influenza Trial in Worldwide (Liquid CAIV-T)
Completed
- Influenza
- Liquid CAIV-T
-
Hoover, Alabama
- +160 more
Sep 10, 2021
Influenza Trial in Rochester (Seasonal IIV 0.25 mL dose, Natural influenza infection, Seasonal IIV 0.5 mL dose)
Completed
- Influenza
- Seasonal IIV 0.25 mL dose
- +2 more
-
Rochester, New YorkUniversity of Rochester
Aug 5, 2021
Influenza, Influenza Immunisation Trial in Rochester (Influenza Virus Quadrivalent Inactivated Vaccine)
Completed
- Influenza
- Influenza Immunisation
- Influenza Virus Quadrivalent Inactivated Vaccine
-
Rochester, New York
- +1 more
Apr 29, 2021
Bird Flu, Influenza Trial in United States (Placebo, Ad4-H5-Vtn, Sanofi Pasteur Influenza Virus Vaccine, H5N1)
Completed
- Bird Flu
- Influenza
- Placebo
- +2 more
-
Lexington, Kentucky
- +3 more
Mar 16, 2020
Influenza Trial in Rochester (H7N3 pLAIV, H7N9 pIIV)
Completed
- Influenza
- H7N3 pLAIV
- H7N9 pIIV
-
Rochester, New YorkUniversity of Rochester Medical Center Vaccine Research Unit (Ou
Mar 22, 2019
Influenza Trial in Worldwide (Amantadine, Ribavirin, Oseltamivir, Oseltamivir)
Completed
- Influenza
- Amantadine, Ribavirin, Oseltamivir
- Oseltamivir
-
Birmingham, Alabama
- +90 more
Jan 31, 2019
Influenza Trial in Worldwide (GSK Bio's influenza vaccine GSK2186877A, Fluarix TM)
Completed
- Influenza
- GSK Bio's influenza vaccine GSK2186877A
- Fluarix TM
-
Alabaster, Alabama
- +273 more
May 8, 2018
Influenza Trial in Canada, United States (Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted, Placebo)
Completed
- Influenza
- Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted
- Placebo
-
Huntsville, Alabama
- +39 more
May 9, 2018
Influenza Trial in Worldwide (Influsplit Tetra™ vaccine produced by investigational process (IP), Influsplit Tetra™ vaccine
Completed
- Influenza
- Influsplit Tetra™ vaccine produced by investigational process (IP)
- Influsplit Tetra™ vaccine produced by licensed process (LP)
-
Wichita, Kansas
- +52 more
May 31, 2018
Influenza Trial in United States (CSL Limited Influenza Virus Vaccine (Afluria®), US Licensed Influenza Virus Vaccine
Completed
- Influenza
- CSL Limited Influenza Virus Vaccine (Afluria®)
- US Licensed Influenza Virus Vaccine (Fluzone®)
-
Mountain Home, Arkansas
- +12 more
Apr 25, 2018
Influenza Trial in Rochester (H3N2v MN 2010/AA ca live attenuated influenza vaccine (LAIV), H3N2v inactivated subvirion
Terminated
- Influenza
- H3N2v MN 2010/AA ca live attenuated influenza vaccine (LAIV)
- +2 more
-
Rochester, New YorkUniversity of Rochester Medical Center (URMC), Vaccine Research
May 1, 2018